Bone Biologics Corp. (BBLG)
0.5615
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 16:00
0.5615
0.00 (0.00%)
After-Hours: 17:28
Bone Biologics Total Assets (Quarterly) : 4.437M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.437M |
| March 31, 2026 | 4.979M |
| December 31, 2025 | 5.796M |
| September 30, 2025 | 6.351M |
| June 30, 2025 | 7.002M |
| March 31, 2025 | 3.162M |
| December 31, 2024 | 3.861M |
| September 30, 2024 | 4.066M |
| June 30, 2024 | 3.194M |
| March 31, 2024 | 3.840M |
| December 31, 2023 | 3.738M |
| September 30, 2023 | 4.976M |
| June 30, 2023 | 7.623M |
| March 31, 2023 | 6.784M |
| December 31, 2022 | 8.495M |
| September 30, 2022 | 5.201M |
| June 30, 2022 | 5.659M |
| March 31, 2022 | 6.094M |
| December 31, 2021 | 6.675M |
| September 30, 2021 | 0.0524M |
| June 30, 2021 | 0.0044M |
| March 31, 2021 | 0.0712M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.0025M |
| June 30, 2020 | 0.0014M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.007M |
| December 31, 2019 | 0.0308M |
| September 30, 2019 | 0.2493M |
| June 30, 2019 | 0.2664M |
| March 31, 2019 | 0.8141M |
| December 31, 2018 | 1.041M |
| September 30, 2018 | 2.350M |
| June 30, 2018 | 0.3777M |
| March 31, 2018 | 0.4705M |
| December 31, 2017 | 0.7957M |
| September 30, 2017 | 1.940M |
| June 30, 2017 | 1.140M |
| March 31, 2017 | 1.968M |
| December 31, 2016 | 0.7011M |
| September 30, 2016 | 1.072M |
| June 30, 2016 | 2.635M |
| March 31, 2016 | 4.622M |
| December 31, 2015 | 2.080M |
| September 30, 2015 | 3.302M |
| June 30, 2015 | 4.413M |
| March 31, 2015 | |
| December 31, 2014 | 3.821M |
| September 30, 2014 | 0.4201M |
| June 30, 2014 | 0.1261M |
| January 31, 2014 | 0.0001M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.512M |
| Shareholders Equity (Quarterly) | 3.925M |
| Current Ratio | 8.665 |